Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors

Agarwal, 1998, Comparative genomic hybridization analysis of human parathyroid tumors, Cancer Genet. Cytogenet., 106, 30, 10.1016/S0165-4608(98)00049-1 Agarwal, 2009, Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states, J. Clin. Endocrinol. Metab., 94, 1826, 10.1210/jc.2008-2083 Aldinger, 1982, Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer, Cancer, 49, 388, 10.1002/1097-0142(19820115)49:2<388::AID-CNCR2820490230>3.0.CO;2-F Andreasson, 2012, Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes, Fam. Cancer, 11, 355, 10.1007/s10689-012-9520-z Apel, R.L., Asa, S.L., 2002. The parathyroid glands. In: LiVolsi, V., Asa, S. (Eds.), Endocrine Pathology. Churchill Livingstone, Philadelphia, pp. 103–147. Arnold, 1995, The cyclin D1/PRAD1 oncogene in human neoplasia, J. Investig. Med., 43, 543 Arnold, A., Marx, S.J., 2008. Familial hyperparathyroidism. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, pp. 361–366. Arnold, 2005, Cyclin D1 in breast cancer pathogenesis, J. Clin. Oncol., 23, 4215, 10.1200/JCO.2005.05.064 Bai, 2007, p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors, Mol. Cell. Biol., 27, 1495, 10.1128/MCB.01764-06 Belar, 2012, Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain, Clin. Endocrinol. (Oxf.), 76, 719, 10.1111/j.1365-2265.2011.04269.x Berland, 1982, Parathyroid carcinoma, adenoma and hyperplasia in a case of chronic renal insufficiency on dialysis, Clin. Nephrol., 18, 154 Bjorklund, 2007, Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors, J. Clin. Endocrinol. Metab., 92, 338, 10.1210/jc.2006-1197 Bjorklund, 2007, An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling, PLoS Med., 4, e328, 10.1371/journal.pmed.0040328 Bjorklund, 2008, Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients, Mol. Cancer, 7, 53, 10.1186/1476-4598-7-53 Bradley, 2006, Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours, Clin. Endocrinol. (Oxf.), 64, 299, 10.1111/j.1365-2265.2006.02460.x Bricaire, 2013, Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism, J. Clin. Endocrinol. Metab., 98, E403, 10.1210/jc.2012-2789 Brown, 2000, Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia, J. Clin. Endocrinol. Metab., 85, 868 Buchwald, 2004, Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism, Clin. Endocrinol. (Oxf.), 60, 389, 10.1111/j.1365-2265.2004.01995.x Buchwald, 2005, Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review), Int. J. Mol. Med., 15, 701 Cantley, 1985, 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture, Endocrinology, 117, 2114, 10.1210/endo-117-5-2114 Carling, 1998, Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism, J. Clin. Endocrinol. Metab., 83, 2960 Carling, 1998, Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors, J. Clin. Endocrinol. Metab., 83, 2255 Carling, 2000, Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism, J. Clin. Endocrinol. Metab., 85, 2000 Carling, 2003, Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas, Surgery, 134, 932, 10.1016/S0039-6060(03)00422-7 Cascon, 2011, Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family, Genes Chromosom. Cancer, 50, 922, 10.1002/gcc.20911 Cetani, 1999, No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas, J. Bone Miner. Res., 14, 878, 10.1359/jbmr.1999.14.6.878 Cetani, 2004, Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors, J. Clin. Endocrinol. Metab., 89, 5583, 10.1210/jc.2004-0294 Cetani, 2007, Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?, Eur. J. Endocrinol., 156, 547, 10.1530/EJE-06-0720 Cetani, 2010, Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas, Endocr. Relat. Cancer, 17, 1, 10.1677/ERC-09-0147 Chandrasekharappa, 1997, Positional cloning of the gene for multiple endocrine neoplasia-type 1, Science, 276, 404, 10.1126/science.276.5311.404 Clevers, 2006, Wnt/beta-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018 Costa-Guda, 2007, Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas, J. Clin. Endocrinol. Metab., 92, 1564, 10.1210/jc.2006-2554 Costa-Guda, 2007, Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas, BMC Endocr. Disord., 7, 8, 10.1186/1472-6823-7-8 Costa-Guda, 2011, Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas, J. Clin. Endocrinol. Metab., 96, E701, 10.1210/jc.2010-1338 Costa-Guda, 2013, Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins, Endocrine, 10.1007/s12020-013-9903-4 Costa-Guda, 2013, Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas, Horm. Cancer, 10.1007/s12672-013-0147-9 Crabtree, 2001, A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors, Proc. Natl. Acad. Sci. USA, 98, 1118, 10.1073/pnas.98.3.1118 Cromer, 2012, Identification of somatic mutations in parathyroid tumors using whole-exome sequencing, J. Clin. Endocrinol. Metab., 97, E1774, 10.1210/jc.2012-1743 Cryns, 1994, P53 abnormalities in human parathyroid carcinoma, J. Clin. Endocrinol. Metab., 78, 1320 DeLellis, 2011, Parathyroid tumors and related disorders, Mod. Pathol., 24, S78, 10.1038/modpathol.2010.132 Demay, 1992, Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3, Proc. Natl. Acad. Sci. USA, 89, 8097, 10.1073/pnas.89.17.8097 Desch, 1984, Parathyroid hyperplasia and carcinoma within one gland, Am. J. Med., 77, 131, 10.1016/0002-9343(84)90447-9 Domingues, 2012, Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism, ∗∗∗Clin. Endocrinol. (Oxf.), 76, 33, 10.1111/j.1365-2265.2011.04184.x Erickson, 1998, Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors, Mod. Pathol., 11, 169 Farnebo, 1998, Alterations of the MEN1 gene in sporadic parathyroid tumors, J. Clin. Endocrinol. Metab., 83, 2627 Farnebo, 1999, Alternative genetic pathways in parathyroid tumorigenesis, J. Clin. Endocrinol. Metab., 84, 3775 Franklin, 2000, Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity, Mol. Cell. Biol., 20, 6147, 10.1128/MCB.20.16.6147-6158.2000 Fritz, 2002, Recessive transmission of a multiple endocrine neoplasia syndrome in the rat, Cancer Res., 62, 3048 Georgitsi, M., XXXX. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Pract. Res. Clin. Endocrinol. Metab. 24(3), 425–437. Gill, 2006, Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias, Am. J. Surg. Pathol., 30, 1140, 10.1097/01.pas.0000209827.39477.4f Guarnieri, 2006, Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance, J. Clin. Endocrinol. Metab., 91, 2827, 10.1210/jc.2005-1239 Guarnieri, 2010, Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years, J. Clin. Endocrinol. Metab., 95, 1819, 10.1210/jc.2008-2430 Guarnieri, 2012, A rare S33C mutation of CTNNB1 encoding beta-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort, Endocrine, 41, 152, 10.1007/s12020-011-9558-y Haghighi, 1983, Concurrent primary parathyroid hyperplasia and parathyroid carcinoma, Arch. Pathol. Lab. Med., 107, 349 Haglund, 2010, Lack of S37A CTNNB1/beta-catenin mutations in a Swedish cohort of 98 parathyroid adenomas, Clin. Endocrinol. (Oxf.), 73, 552 Hakim, 1994, Absence of p53 point mutations in parathyroid adenoma and carcinoma, J. Clin. Endocrinol. Metab., 78, 103 Harding, 2009, Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia, Endocr. Relat. Cancer, 16, 1313, 10.1677/ERC-09-0082 Heppner, 1997, Somatic mutation of the MEN1 gene in parathyroid tumours, Nat. Genet., 16, 375, 10.1038/ng0897-375 Ho, 1995, A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Nat. Genet., 11, 389, 10.1038/ng1295-389 Hosokawa, 1995, Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors, J. Clin. Endocrinol. Metab., 80, 3107 Howell, 2003, HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours, J. Med. Genet., 40, 657, 10.1136/jmg.40.9.657 Hsi, 1996, Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study, J. Clin. Endocrinol. Metab., 81, 1736 Hunt, 2005, Allelic loss in parathyroid neoplasia can help characterize malignancy, Am. J. Surg. Pathol., 29, 1049, 10.1097/01.pas.0000166368.68459.99 Ikeda, 2002, Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas, Int. J. Oncol., 20, 463 Ilyas, 2005, Wnt signalling and the mechanistic basis of tumour development, J. Pathol., 205, 130, 10.1002/path.1692 Imanishi, 2001, Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice, J. Clin. Invest., 107, 1093, 10.1172/JCI10523 Juhlin, 2009, Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas, Int. J. Oncol., 34, 481 Juhlin, 2010, Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours, PLoS One, 5, e9472, 10.1371/journal.pone.0009472 Kang, 2011, Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein, J. Biol. Chem., 286, 16758, 10.1074/jbc.M110.210120 Karim, 2004, The significance of the Wnt pathway in the pathology of human cancers, Pathology, 36, 120, 10.1080/00313020410001671957 Kasaian, 2013, Complete genomic landscape of a recurring sporadic parathyroid carcinoma, J. Pathol., 230, 249, 10.1002/path.4203 Krebs, 2005, HRPT2 mutational analysis of typical sporadic parathyroid adenomas, J. Clin. Endocrinol. Metab., 90, 5015, 10.1210/jc.2005-0717 Kytola, 2000, Patterns of chromosomal imbalances in parathyroid carcinomas, Am. J. Pathol., 157, 579, 10.1016/S0002-9440(10)64568-3 Li, 1998, Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice, Endocrinology, 139, 4391, 10.1210/endo.139.10.6262 Libutti, 2003, Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism, Cancer Res., 63, 8022 Lin, 2008, The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene, Proc. Natl. Acad. Sci. USA, 105, 17420, 10.1073/pnas.0710725105 Meir, 2009, Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology, Am. J. Physiol. Renal Physiol., 297, F1192, 10.1152/ajprenal.00360.2009 Morin, 1997, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC, Science, 275, 1787, 10.1126/science.275.5307.1787 Mosimann, 2006, Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo, Cell, 125, 327, 10.1016/j.cell.2006.01.053 Motokura, 1991, A novel cyclin encoded by a bcl1-linked candidate oncogene, Nature, 350, 512, 10.1038/350512a0 Munger, 1963, The cytology of the normal parathyroid glands of man and Virginia deer; a light and electron microscopic study with morphologic evidence of secretory activity, J. Cell Biol., 16, 379, 10.1083/jcb.16.2.379 Murayama, 1977, A case of parathyroid carcinoma concurred with hyperplasia: an electron microscopic study, J. Urol., 118, 126, 10.1016/S0022-5347(17)57920-3 Nesbit, 2013, Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia, N. Engl. J. Med., 368, 2476, 10.1056/NEJMoa1300253 Nesbit, 2013, Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3, Nat. Genet., 45, 93, 10.1038/ng.2492 Newey, 2010, Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors, Hum. Mutat., 31, 295, 10.1002/humu.21188 Newey, 2012, Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas, J. Clin. Endocrinol. Metab., 97, E1995, 10.1210/jc.2012-2303 Nygren, 1988, 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells, Calcif. Tissue Int., 43, 213, 10.1007/BF02555137 Palanisamy, 1998, Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas, J. Clin. Endocrinol. Metab., 83, 1766 Pardi, 2013, Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas, J. Clin. Endocrinol. Metab., 98, 2800, 10.1210/jc.2012-4029 Pausova, 1996, Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2, J. Clin. Endocrinol. Metab., 81, 2711 Pearce, 1996, A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor, N. Engl. J. Med., 335, 1115, 10.1056/NEJM199610103351505 Pellegata, 2006, Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans, Proc. Natl. Acad. Sci. USA, 103, 15558, 10.1073/pnas.0603877103 Pollak, 1993, Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Cell, 75, 1297, 10.1016/0092-8674(93)90617-Y Sakai, 2002, Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses, Am. J. Surg. Pathol., 26, 103, 10.1097/00000478-200201000-00014 Samander, 2006, Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas, J. Clin. Endocrinol. Metab., 91, 5019, 10.1210/jc.2006-1543 Semba, 2000, Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity, Endocr. Pathol., 11, 243, 10.1385/EP:11:3:243 Shattuck, 2003, Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma, Clin. Endocrinol. (Oxf.), 59, 180, 10.1046/j.1365-2265.2003.01814.x Shattuck, 2003, Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma, N. Engl. J. Med., 349, 1722, 10.1056/NEJMoa031237 Shtutman, 1999, The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway, Proc. Natl. Acad. Sci. USA, 96, 5522, 10.1073/pnas.96.10.5522 Silver, 1999, Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate, Kidney Int. Suppl., 73, S2, 10.1046/j.1523-1755.1999.07310.x Silverberg, 1999, The effects of vitamin D insufficiency in patients with primary hyperparathyroidism, Am. J. Med., 107, 561, 10.1016/S0002-9343(99)00294-6 Starker, 2011, The DNA methylome of benign and malignant parathyroid tumors, Genes Chromosome Cancer, 50, 735, 10.1002/gcc.20895 Starker, 2012, Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism, Horm. Cancer, 3, 44, 10.1007/s12672-011-0100-8 Starker, 2012, Evidence of a stabilizing mutation of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas, Endocrine, 42, 612, 10.1007/s12020-012-9690-3 Steele-Perkins, 2001, Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily, Genes Dev., 15, 2250, 10.1101/gad.870101 Sulaiman, 2012, Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors, PLoS One, 7, e46325, 10.1371/journal.pone.0046325 Svedlund, 2010, Aberrant WNT/beta-catenin signaling in parathyroid carcinoma, Mol. Cancer, 9, 294, 10.1186/1476-4598-9-294 Svedlund, 2012, Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification, J. Clin. Endocrinol. Metab., 97, E1307, 10.1210/jc.2011-3136 Tahara, 1996, Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas, Cancer Res., 56, 599 Tan, 2004, Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma, Clin. Cancer Res., 10, 6629, 10.1158/1078-0432.CCR-04-0493 Tanaka, 2002, Biallelic inactivation by somatic mutations of the MEN1 gene in sporadic parathyroid tumors, Cancer Lett., 175, 175, 10.1016/S0304-3835(01)00729-7 Tetsu, 1999, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells, Nature, 398, 422, 10.1038/18884 Thakker R. V., Multiple Endocrine Neoplasia Type 1 and MEN-X, Mol. Cell. Endocrinol, in this issue. Doi: 10.1016/j.mce.2013.08.002 Tokumoto, 2002, Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism, Kidney Int., 62, 1196, 10.1111/j.1523-1755.2002.kid585.x Tominaga, 1999, Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma, Kidney Int., 55, 1375, 10.1046/j.1523-1755.1999.00396.x Vasef, 1999, Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study, Mod. Pathol., 12, 412 Vogelstein, 1989, Allelotype of colorectal carcinomas, Science, 244, 207, 10.1126/science.2565047 Wang, 2008, Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice, Mol. Cell. Biol., 28, 2930, 10.1128/MCB.00654-07 Westin, 2009, Molecular genetics of parathyroid disease, World J. Surg., 33, 2224, 10.1007/s00268-009-0022-6 Woodard, 2005, Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression, Oncogene, 24, 1272, 10.1038/sj.onc.1208274 Yap, 2011, Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation, Blood, 117, 2451, 10.1182/blood-2010-11-321208